Suzhou Zelgen Biopharmaceuticals Co., Ltd.

65
Hold
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003RP1
CNY
110.34
-8.24 (-6.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
531.00
385.00
300.00
189.00
26.00
0.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
531.00
385.00
300.00
189.00
26.00
0.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
275.00
258.00
307.00
237.00
133.00
293.00
Operating Expenses
29.00
24.00
14.00
6.00
1.00
1.00
General and Administration Expenses
313.00
251.00
298.00
211.00
91.00
265.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
758.00
794.00
839.00
737.00
407.00
450.00
Operating Profit (PBDIT) excl Other Income
-226.00
-408.00
-538.00
-547.00
-381.00
-450.00
Other Income
94.00
125.00
63.00
86.00
73.00
16.00
Operating Profit (PBDIT)
-68.00
-222.00
-404.00
-407.00
-261.00
-400.00
Interest
29.00
24.00
14.00
6.00
1.00
1.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
61.00
60.00
70.00
53.00
46.00
33.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-155.00
-299.00
-487.00
-465.00
-304.00
-439.00
Provision for Tax
-4.00
-3.00
-2.00
-3.00
5.00
8.00
Profit After Tax
-137.00
-278.00
-457.00
-450.00
-319.00
-461.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-0.52
-1.09
-1.91
-1.88
-1.33
-1.92
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 37.90% vs 28.07% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 44.50% vs 24.15% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 19.00% vs 63.65% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 50.52% vs 39.08% in Dec 2023

Compare Profit and Loss Results of Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
531.00
0
531.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
531.00
0
531.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
275.00
0
275.00
0%
Operating Expenses
29.00
0
29.00
0%
General and Administration Expenses
313.00
0
313.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
758.00
0
758.00
0%
Operating Profit (PBDIT) excl Other Income
-226.00
0.00
-226.00
0%
Other Income
94.00
0
94.00
0%
Operating Profit (PBDIT)
-68.00
0
-68.00
0%
Interest
29.00
0
29.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
61.00
0
61.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
-155.00
0
-155.00
0%
Provision for Tax
-4.00
0
-4.00
0%
Profit After Tax
-137.00
0
-137.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.5207
0
-0.52
0%
Profit And Loss - Net Sales
Net Sales 531.51 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 37.90% vs 28.07% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -226.88 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 44.50% vs 24.15% in Dec 2023

Profit And Loss - Interest
Interest 29.10 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 19.00% vs 63.65% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax -137.83 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 50.52% vs 39.08% in Dec 2023